COVID-19 does cause gas, bloating, and a range of other digestive problems in a substantial number of people who get infected. These symptoms can appear during the acute illness alongside the more familiar fever and cough, or they can develop afterward and linger for months. The gut is not a bystander in a COVID infection; the virus directly invades cells lining the small intestine, disrupts the gut microbiome, and can trigger lasting changes in how the digestive system functions. What surprises many people is that for some patients, digestive complaints are the main symptoms, and respiratory problems barely register.
How Common Are Digestive Symptoms During Acute COVID
Early in the pandemic, COVID was framed almost entirely as a respiratory illness, and gut symptoms were underreported. As larger studies accumulated, the picture changed. A meta-analysis in the Annals of Gastroenterology found that roughly one in ten hospitalized adults reported digestive symptoms overall, with diarrhea appearing in about 10%, nausea or vomiting in about 8%, and abdominal pain in about 7%.1PubMed Central. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis Those numbers, though, came mostly from early waves and likely undercount the true rate, because many studies relied on patients volunteering symptoms rather than being systematically asked.
A prospective multinational study that actively screened for gut complaints found a much higher figure: about 60% of hospitalized COVID patients reported at least one digestive symptom, compared with about 43% of hospitalized controls without COVID.2PubMed Central. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study Diarrhea was reported by about 38% of COVID patients versus 12% of controls. Nausea appeared in about 28% versus 13%. The COVID group also had more loose stools and urgency, while constipation was actually less common in COVID patients than in the control group. The gap between the earlier meta-analyses and this prospective study illustrates a simple point: when you look for gut symptoms, you find them far more often.
Why the Virus Targets the Gut
SARS-CoV-2 enters human cells by latching onto a receptor called ACE2. Most of the attention on ACE2 has focused on the lungs, but the receptor is also abundant in the lining of the small intestine, especially on the mature absorptive cells called enterocytes.3PubMed Central. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection Research using lab-grown miniature intestines confirmed that the virus productively infects these cells, replicating inside them just as it does in lung tissue.4PubMed Central. SARS-CoV-2 productively infects human gut enterocytes The infection damages the intestinal lining, which can loosen the gut’s barrier and allow inflammatory molecules to leak into the bloodstream.5PubMed Central. Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients
This direct invasion helps explain why gut symptoms can appear even before respiratory ones do, and why viral RNA is frequently found in stool. The meta-analysis mentioned above detected SARS-CoV-2 RNA in fecal samples of about 30% of patients.1PubMed Central. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis Separate work confirmed that viral RNA can persist in stool even after respiratory swabs have turned negative.6PubMed. Persistence of viral RNA in stool samples from patients recovering from covid-19 In other words, the virus is not just passing through the gut; it is actively setting up shop there.
Gas, Bloating, and Flatulence in Particular
If your main concern is specifically gas and bloating rather than diarrhea or nausea, you are not imagining things. A systematic review of COVID-related gastrointestinal autonomic dysfunction found that bloating, belching, and irregular bowel movements were among the recognized symptoms, alongside the more commonly discussed diarrhea and abdominal pain.7PubMed Central. COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review A study of patients with post-acute COVID syndrome and a related condition called postural orthostatic tachycardia syndrome found that bloating and flatulence were the single most commonly reported gut symptoms in both groups.8Scientific Reports. Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome
A questionnaire-based survey that tracked specific symptoms over time found that excess gas and constipation tended to be among the most stubborn complaints, persisting for more than six months in many patients, while abdominal pain and nausea typically resolved sooner.9PubMed Central. Acute gastrointestinal and post-acute COVID-19 gastrointestinal syndrome assessment on the Gastrointestinal Symptom Rating Scale scoring system Gas does not get the same attention as diarrhea in most medical literature, partly because it is harder to measure objectively. But for the people dealing with it daily, it is a real and sometimes socially disruptive symptom.
When Digestive Problems Outlast the Infection
For many people, gut symptoms do not stop when the acute illness ends. A meta-analysis in Therapeutic Advances in Gastroenterology estimated that about 22% of people with long COVID experienced digestive symptoms, compared with about 12% of COVID patients in general. Common long-term complaints included loss of appetite (around 20%), loss of taste (around 17%), abdominal pain (around 14%), and diarrhea (around 10%).10PubMed Central. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis That same analysis also estimated the frequency of dyspepsia, a catch-all term for upper-belly discomfort, at about 20%, and irritable bowel syndrome at about 17% in the long COVID population.
A large study using U.S. Veterans Affairs data tracked gastrointestinal outcomes over a full year after COVID infection. The results showed increased risks of motility disorders, acid-related conditions like reflux and dyspepsia, functional intestinal disorders, and even acute pancreatitis, compared with people who had never been infected.11Nature Communications. Long-term gastrointestinal outcomes of COVID-19 These were not trivial bumps in incidence; they spanned a wide range of digestive diagnoses and persisted well beyond the first month.
One observational study found that 44% of participants still reported gut symptoms 12 weeks after hospital discharge, with loss of appetite, nausea, acid reflux, diarrhea, and abdominal distension being the most common. An important finding was that patients who developed lasting gut problems almost always had some digestive symptoms during their initial illness as well.12PubMed Central. Digestive involvement in the Long-COVID syndrome Having digestive complaints during the acute phase appears to be a signal that you are more likely to deal with them later.
Post-COVID IBS and Bacterial Overgrowth
Infectious triggers for irritable bowel syndrome are well established in gastroenterology; bacterial food poisoning, for example, is a known IBS trigger. It is not surprising, then, that researchers investigated whether COVID could do the same. A meta-analysis found a pooled IBS frequency of about 12% in post-COVID cohorts, though estimates varied widely across studies.13PubMed Central. Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review A Japanese retrospective study placed the number lower, at about 2% of hospitalized patients, but identified nausea and diarrhea during the acute illness as risk factors that made post-infection IBS several times more likely.14PubMed Central. Early symptoms preceding post-infectious irritable bowel syndrome following COVID-19
Another condition gaining attention is small intestinal bacterial overgrowth, or SIBO, in which bacteria that normally stay in the large intestine colonize the small intestine and produce excess gas, bloating, and diarrhea. A global population-based study found that COVID significantly increased the risk of SIBO, particularly within the first 12 months after infection.15PubMed Central. Progressive Increase in Small Intestinal Bacterial Overgrowth Risk Following COVID-19 Infection: A Global Population-Based Study A prospective cohort study also found that among patients with persistent gut symptoms at three months, about 30% tested positive for isolated carbohydrate malabsorption, and a smaller number had intestinal methanogen overgrowth.16PubMed Central. Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study Carbohydrate malabsorption means certain sugars are not absorbed properly and ferment in the gut, producing gas and bloating. If you have been dealing with unexplained gassiness after a COVID infection, SIBO or malabsorption could be worth investigating with your doctor.
How COVID Reshapes the Gut Microbiome
Beyond direct damage to intestinal cells, COVID broadly disrupts the ecosystem of bacteria, fungi, and viruses that live in the gut. Studies have consistently found that patients with COVID have reduced microbiome diversity, with fewer beneficial bacteria and a rise in opportunistic ones.17Genomics, Proteomics & Bioinformatics. Gut Microbiome Alterations in COVID-19 The overall ecological network of gut microbes becomes sparser and weaker. These shifts correlate with disease severity and seem to play into the inflammatory response.18Nature Reviews Gastroenterology & Hepatology. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Antibiotic use during hospitalization makes things worse. A study tracking specific bacterial groups found that hospitalized COVID patients treated with antibiotics showed a more pronounced imbalance, including an increase in Enterococcus bacteria and a decrease in beneficial Roseburia bacteria. The degree of imbalance correlated with markers of inflammation and with the length and severity of the hospital stay.19PubMed Central. Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp. This matters because a destabilized microbiome does not always bounce back quickly; research shows that the altered gut microbiome persists in a significant subset of patients even after the infection clears, coinciding with long COVID symptoms.17Genomics, Proteomics & Bioinformatics. Gut Microbiome Alterations in COVID-19
Can probiotics help? There is some early evidence that strains of Lactobacillus and Bifidobacterium have immunomodulatory properties relevant to viral infections, including reducing inflammatory markers and supporting antiviral immune responses. However, data on using probiotics specifically for COVID-related gut symptoms remains limited, and researchers stress that clinical investigation is still in its early stages.20PubMed. Probiotics and Prebiotics Intervention in Respiratory and Digestive Infections Linked to Covid-19 Translation: probiotics are unlikely to hurt you, but there is not yet strong evidence they will fix post-COVID gut dysfunction specifically.
The Vagus Nerve Connection
One of the more intriguing explanations for persistent digestive symptoms involves the vagus nerve, the long nerve that connects the brain to the gut and controls peristalsis, the wave-like muscular contractions that push food through the digestive tract. A pilot study comparing people with post-COVID condition to recovered controls found that post-COVID patients were more likely to show abnormalities in their vagus nerve on ultrasound, including thickening of the nerve. More strikingly, about a third of post-COVID patients had reduced peristalsis through the esophagus, stomach, and intestine, and a similar proportion had gastroesophageal reflux, compared with much lower rates in both control groups.21PubMed. Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study
If the vagus nerve is not firing properly, the gut slows down. Sluggish motility means food sits longer in the intestines, giving bacteria more time to ferment it, which produces gas. It also makes reflux and bloating worse. Researchers have proposed that disrupted signaling along the microbiota-gut-brain axis, the bidirectional communication system between the gut microbiome, the nervous system, and the brain, plays a role in the development of post-acute COVID symptoms including both digestive and neuropsychiatric complaints.22PubMed Central. Role of the microbiota-gut-brain axis in postacute COVID syndrome This may help explain why post-COVID patients often report gut symptoms alongside brain fog and fatigue rather than as isolated complaints.
Viral Persistence in the Gut
One hypothesis for why gut symptoms drag on is that the virus, or pieces of it, may linger in the intestinal lining long after the acute infection resolves. A study of patients with inflammatory bowel disease found SARS-CoV-2 RNA in the gut lining of about 70% of participants roughly seven months after a mild acute infection. Viral protein was also detectable in the gut tissue of about half the group, even though none of them had detectable virus in their stool.23PubMed Central. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases The persistence of these viral remnants could trigger ongoing low-grade inflammation and immune activation in the gut, which in turn drives symptoms. Various theories about the mechanisms behind long COVID overlap here, including autoimmune responses, chronic inflammation, and disruption of the gut barrier.24PubMed Central. Mechanisms of Gut-Related Viral Persistence in Long COVID
Abdominal Pain and Disease Severity
Not all gut symptoms carry the same clinical weight. A systematic review and meta-analysis specifically looking at severe versus non-severe COVID found that abdominal pain was significantly more common in patients with severe disease, with roughly 2.7 times the odds compared with milder cases. Diarrhea, nausea, and vomiting, by contrast, showed no significant difference between the severe and non-severe groups.25PubMed Central. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis This does not mean that diarrhea or gas are trivial, only that abdominal pain in the context of a COVID infection deserves closer clinical attention as a potential marker of more serious disease.
In rare and severe cases, COVID can cause blood-vessel clotting that affects the gut directly. A systematic review of imaging findings found cases of mesenteric artery or vein clots leading to bowel ischemia, where sections of the intestine lose their blood supply.26PubMed Central. Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation Case reports have documented bowel ischemia appearing as the first sign of COVID, even in patients whose respiratory swabs were still negative.27PubMed Central. Bowel ischemia as onset of COVID‐19 in otherwise asymptomatic patients with persistently negative swab These are uncommon complications of severe disease, not something most people with COVID will face, but they underline that the virus can affect the gut through vascular routes as well as direct infection.
Children and Gut Symptoms in MIS-C
Children generally experience milder acute COVID than adults, but when the rare inflammatory complication called MIS-C (multisystem inflammatory syndrome in children) develops, gut symptoms can be front and center. A meta-analysis of MIS-C presentations found that abdominal pain was present in about 74% of cases, vomiting in about 69%, and diarrhea in about 62%.28PubMed Central. Meta-analysis on clinical manifestation and laboratory parameters of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) In some cases, the abdominal presentation was severe enough to mimic appendicitis, leading to exploratory surgery that found no actual appendicitis.29PubMed Central. Pediatric Gastrointestinal Disorders in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19: A Case Series MIS-C typically appears weeks after the initial infection, often after the respiratory swab has already turned negative. Parents who see their child develop intense abdominal pain and high fever in the weeks following a known COVID exposure should be aware that MIS-C is a possibility.
Can COVID Vaccines Cause Digestive Symptoms Too
Some people report digestive changes after vaccination rather than infection. A cross-sectional study found that bloating and flatulence were the most frequently reported severe gut side effects after the first vaccine dose, each affecting roughly 7-8% of respondents, while heartburn was the most common moderate gut side effect at about 13%.30PubMed Central. Association Between COVID‐19 Vaccination and Gastrointestinal Manifestations: A Cross‐Sectional Study A separate dataset found that about a third of people who reported post-vaccination side effects noticed changes in their gut activity, with a quarter saying those changes appeared within one to two days of the shot.31Data in Brief. Data Article Investigating the association between the COVID-19 vaccination and incident gastrointestinal symptomology: A comprehensive dataset
These vaccine-related gut effects are generally short-lived and mild compared with the digestive consequences of an actual SARS-CoV-2 infection. The vaccine delivers instructions for building the spike protein, which triggers an immune response, but it does not invade gut enterocytes, disrupt the microbiome in the same sustained way, or carry any risk of the lasting post-infection syndromes described above. Still, knowing that temporary gassiness or looser stools can follow a vaccine dose is useful so you do not mistake it for a new illness.
Practical Steps if You Are Dealing With Post-COVID Gut Symptoms
If your digestive issues have persisted for weeks or months after a COVID infection, there are a few things worth knowing. First, you are dealing with something real and documented, not something psychosomatic. Second, the underlying causes can vary from person to person: microbiome disruption, carbohydrate malabsorption, slow motility, SIBO, or lingering gut inflammation may all play roles. A gastroenterologist can test for SIBO with a breath test and evaluate for malabsorption or motility problems.
The evidence on targeted treatments is still developing. Probiotics have biological plausibility but not yet strong clinical trial data for this specific context.20PubMed. Probiotics and Prebiotics Intervention in Respiratory and Digestive Infections Linked to Covid-19 Standard IBS management strategies, including dietary modifications like reducing fermentable carbohydrates, managing stress, and staying physically active, are reasonable starting points while the science catches up. If you had gut symptoms during your acute illness, you are at higher risk for persistent problems and should mention that history to your doctor rather than waiting for things to resolve on their own.